- First patient enrolled in trial evaluating Tome Clearing Treatment for once-weekly acne care.
- Company targets commercial launch for this second product candidate in H1 2027.
?? Positive AI Sentiment (+2.5 / 10)
Single signal · #46242
$DRMA — AI Filing Signal
Public delayed archive entry for this Stock Catalyst AI alert.